Chuck Grassley actually said...
However, an enforcement case would, at the minimum, give us a framework and a timeline to resolve the COFEPRIS-regulated delays in biotechnology approvals.
Context
Grassley emphasizes the need for enforcement to resolve biotech approval delays.
07/26/2021